Liu Nanmei, Lo Louis Shi-li, Askary S Hassan, Jones LaTrice, Kidane Theodros Z, Trang Trisha, Nguyen Minh, Goforth Jeremy, Chu Yu-Hsiang, Vivas Esther, Tsai Monta, Westbrook Terence, Linder Maria C
Department of Chemistry and Biochemistry, California State University, Fullerton, CA 92834-6866, USA.
J Nutr Biochem. 2007 Sep;18(9):597-608. doi: 10.1016/j.jnutbio.2006.11.005. Epub 2007 Mar 23.
Transcuprein is a high-affinity copper carrier in the plasma that is involved in the initial distribution of copper entering the blood from the digestive tract. To identify and obtain cDNA for this protein, it was purified from rat plasma by size exclusion and copper-chelate affinity chromatography, and amino acid sequences were obtained. These revealed a 190-kDa glycosylated protein identified as the macroglobulin alpha(1)-inhibitor III, the main macroglobulin of rodent blood plasma. Albumin (65 kDa) copurified in variable amounts and was concluded to be a contaminant (although it can transiently bind the macroglobulin). The main macroglobulin in human blood plasma (alpha(2)-macroglobulin), which is homologous to alpha(1)-inhibitor III, also bound copper tightly. Expression of alpha(1)I3 (transcuprein) mRNA by the liver was examined in rats with and without copper deficiency, using quantitative polymerase chain reaction methodology and Northern blot analysis. Protein expression was examined by Western blotting. Deficient rats with 40% less ceruloplasmin oxidase activity and liver copper concentrations expressed about twice as much alpha(1)I3 mRNA, but circulating levels of transcuprein did not differ. Iron deficiency, which increased liver copper concentrations by threefold, reduced transcuprein mRNA expression and circulating levels of transcuprein relative to what occurred in rats with normal or excess iron. We conclude that transcupreins are specific macroglobulins that not only carry zinc but also carry transport copper in the blood, and that their expression can be modulated by copper and iron availability.
转铜蛋白是血浆中的一种高亲和力铜载体,参与从消化道进入血液的铜的初始分布。为了鉴定并获得该蛋白的cDNA,通过尺寸排阻色谱和铜螯合亲和色谱从大鼠血浆中纯化该蛋白,并获得了氨基酸序列。这些序列揭示了一种190 kDa的糖基化蛋白,被鉴定为巨球蛋白α(1)-抑制剂III,即啮齿动物血浆中的主要巨球蛋白。白蛋白(65 kDa)以不同量共纯化,被认为是一种污染物(尽管它可以短暂结合巨球蛋白)。人血浆中的主要巨球蛋白(α(2)-巨球蛋白)与α(1)-抑制剂III同源,也能紧密结合铜。使用定量聚合酶链反应方法和Northern印迹分析,检测了有或没有铜缺乏的大鼠肝脏中α(1)I3(转铜蛋白)mRNA的表达。通过蛋白质印迹法检测蛋白质表达。铜蓝蛋白氧化酶活性和肝脏铜浓度降低40%的缺乏铜大鼠,其α(1)I3 mRNA表达量约为正常大鼠的两倍,但转铜蛋白的循环水平没有差异。缺铁使肝脏铜浓度增加了三倍,相对于正常铁或铁过量的大鼠,缺铁降低了转铜蛋白mRNA的表达和转铜蛋白的循环水平。我们得出结论,转铜蛋白是特定的巨球蛋白,不仅携带锌,还在血液中携带运输铜,并且它们的表达可以受到铜和铁供应情况的调节。